Delivery Order SPE2DR25D2011-SPE2DR26FADQL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, non-set-aside contract has a ceiling value of $67,903.44 with firm fixed pricing and is scheduled for completion by December 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve...
- The Defense Logistics Agency awarded a $13,857.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product for treating autoimmune conditions. This non-set-aside competitive award is scheduled for completion by December 5, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for Humira Pen 40 mg/0.8 mL pharmaceutical products on December 11, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive procurement through the federal supply system. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,473.70 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 9, 2025, with completion scheduled for December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $62,020.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded contract, which carries no set-aside designation, represents a single-dose pharmaceutical delivery under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a $6,204.34 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationships. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $20,373.52 to AmerisourceBergen Drug Corp for the supply of Humira (CF) Pen 40 mg/0.4 mL on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,756.39 to AmerisourceBergen Drug Corp for the supply of Humira (CF) Pen 40 mg/0.4 mL on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this order leverages...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL with a ceiling value of $1,606.84. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating competitive procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,568.34 to supply HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product for federal medical procurement needs. The award was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and utilized firm fixed-price pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADQLDelivery Order
The Defense Logistics Agency awarded a $17,577.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product. This is a non-set-aside competitive award with an ultimate completion date of December 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen Drug Corp fulfills federal medical procurement requirements across the Department of Defense and veteran healthcare systems through its extensive product portfolio of brand-name and generic medications. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of medications and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal procurement standards through open competition, combined with its significant prime indefinite delivery contract, positions it as a major vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 12/17/25 |